(Q37707150)

22 August 2017

1 reference

title

Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases (English)

1 reference

22 August 2017

1 reference

Giorgio Treglia

1

0 references

author name string

Ernesto Cason

2

1 reference

22 August 2017

Anna Gabellini

3

1 reference

22 August 2017

Alessandro Giordano

4

1 reference

22 August 2017

Giorgio Fagioli

5

1 reference

22 August 2017

publication date

10 March 2010

1 reference

22 August 2017

published in

Neurological Sciences

1 reference

22 August 2017

volume

31

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

417-422

1 reference

123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders

22 August 2017

cites work

1 reference

12 December 2020

The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes

1 reference

12 December 2020

Clinical and neuropathological correlates of Lewy body disease

1 reference

12 December 2020

123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder

1 reference

12 December 2020

Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease

1 reference

12 December 2020

Targeting neuronal dysfunction and receptor imaging

1 reference

12 December 2020

Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease.

1 reference

12 December 2020

Is it time for cardiac innervation imaging?

1 reference

12 December 2020

Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy

1 reference

12 December 2020

Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease

1 reference

12 December 2020

Cardiac 123I-MIBG scintigraphy in patients with essential tremor.

1 reference

12 December 2020

Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies

1 reference

12 December 2020

Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.

1 reference

12 December 2020

Neuronal imaging using SPECT.

1 reference

12 December 2020

Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism

1 reference

12 December 2020

Cardiovascular dysautonomia in de novo Parkinson's disease

1 reference

12 December 2020

Early discriminatory diagnosis of dementia with Lewy bodies. The emerging role of CSF and imaging biomarkers

1 reference

12 December 2020

Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease

1 reference

12 December 2020

Cardiac 123I-MIBG scintigraphy in patients with drug induced parkinsonism

1 reference

12 December 2020

Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders.

1 reference

12 December 2020

FP-CIT and MIBG scintigraphy in early Parkinson's disease

1 reference

12 December 2020

The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic

1 reference

12 December 2020

Characteristics of orthostatic hypotension in Parkinson's disease

1 reference

12 December 2020

Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease

1 reference

12 December 2020

Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study

1 reference

12 December 2020

Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease.

1 reference

12 December 2020

Impaired cardiovascular autonomic function in Parkinson's disease with visual hallucinations

1 reference

12 December 2020

Cardiac (123)I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life

1 reference

12 December 2020

Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease

1 reference

12 December 2020

Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease

1 reference

12 December 2020

Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy.

1 reference

12 December 2020

Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder

1 reference

12 December 2020

Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.

1 reference

12 December 2020

Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study

1 reference

12 December 2020

Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.

1 reference

12 December 2020

Cardiovascular autonomic dysfunction in dementia with Lewy bodies and Parkinson's disease

1 reference

12 December 2020

Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease

1 reference

12 December 2020

10.1007/S10072-010-0239-Z

Identifiers

DOI

1 reference

22 August 2017

1 reference